Skip to content
MarketScale
‹ Back to IndustriesSciences

Leaders Driving Change at SXSW: Part Two

The films and music that debut at SXSW every year may be what people remember, but alongside that star power stands innovation that changes the world. There will be no red carpet or paparazzi for the developers of these new products, but surely people around the world will feel their impact for years to…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Software And Technology · Didrik Fjeldstad PodcastDimitrios Psaltis PodcastTrak Lord PodcastTyler Kern Podcast
Share

Key takeaways

01

The films and music that debut at SXSW every year may be what people remember, but alongside that star power stands innovation that changes the world.

02

There will be no red carpet or paparazzi for the developers of these new products, but surely people around the world will feel their impact for years to…

The films and music that debut at SXSW every year may be what people remember, but alongside that star power stands innovation that changes the world. There will be no red carpet or paparazzi for the developers of these new products, but surely people around the world will feel their impact for years to come.

On part II of the MarketScale SXSW Podcast Series, hear how both a 3D printing company and a foreign airline service are making the most out of existing materials and why a team of scientists is trying to capture images of something previously unseen by cameras.

How 3D Printing Is Scaling The Manufacturing Process

Six years after Markforged was founded, the Watertown, Massachusetts-based 3D printing company has made it to SXSW to be recognized as one of the most innovative companies in the digital world for its additive manufacturing software.

Although it did not take home the grand prize in the Robotics and Hardware category at the Innovation Awards on Monday, March 11, Markforged spoke to MarketScale about how the company has become a leader in 3D printing, particularly with metal and carbon fiber products.

Markforged has differentiated itself by printing custom parts and tools for manufacturers with its software program.

“The actual concept for manufacturing is going to radically change because of things like affordable 3D printing,” director of communications Trak Lord told MarketScale.

By essentially storing inventory digitally and having the ability to custom print parts on-demand, any company that uses heavy machinery will be able to cut overhead and storage space.

Education on the topic is still growing and Lord believes SXSW is the perfect place to elevate the profile not only of what Markforged is doing, but all the implications of additive manufacturing.

“3D printing is really kind of the decathlon of technology because it combines material sciences, physics, hardware, software, full stack engineering, so we’re doing all sorts of really cool stuff,” Lord said.

Promoting Sustainability in Travel

Austin, Texas has its fair share of foreign cuisine but this week the capital city is being introduced to something truly different. Scandinavian Airlines is coming to town with hospitality on its mind and is manifesting it in the way of a nine-course meal prepared by a trio of Michelin-starred chefs from Norway, Sweden and Finland.

This meal will not be a classic Scandinavian delicacy though. To promote its message of sustainability, the company is requiring the chefs use entirely food that would otherwise be going to waste.

“We went to a bakery last night and collected some bread crumbs, wasted bread crumbs, that would normally be thrown out. What we’re doing is converting them into pasta dough,” vice president of brand marketing Didrik Fjeldstad said. “So, we’re trying to sort of make a sustainable ecosystem of food and present that to the Austinites.”

Whether it is in the food at the House of Scandinavia at SXSW this week or in the way the aviation company looks at lowering its carbon footprint, Scandinavian Airlines is coming to America with a message of sustainability and hopes to bring other lessons back home.

“We really truly believe that travel makes you better people. When we travel, we become wise, more tolerant, inspired,” Fjeldstad said.

The airline has a goal of 25% reduction of carbon emissions by 2030, according to Fjeldstad, and by hosting the community at House of Scandinavia he hopes local communities can become more aware and engaged in ways to accomplish that.

Photographing A Black Hole

Black holes do not let light escape, according to University of Arizona professor Dimitrios Psaltis, so how does a camera get a photo of one? This is the challenge for Psaltis and the team at Event Horizon Telescope (EHT), a project designed to create an Earth-sized telescope network that can capture images of black holes.

“Most of the time what we do in science, is as you said, is taking a tiny little step that is completely inconsequential,” Psaltis said. “And yet, once every generation, once every two generations we are lucky enough to be in front of something major like taking a picture of a black hole. To me at least, that is not something that happens all the time.”

Psaltis spoke over the weekend about the progress EHT has made since it launched in 2017 and how this endeavor will give people a better understanding of Albert Einstein’s theory of general relativity. Images and findings from the project are expected to be revealed later this year.

Stay tuned for part III of MarketScale’s series of conversation with SXSW speakers and the leaders driving change in their industries, coming out tomorrow, Thursday, March 14.

For the latest news, videos, and podcasts in the Software & Electronics Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @TechMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

About the author

SA
Software And Technology

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

SA
Software And Technology

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512